{"id":"W4310119573","doi":"10.1182/blood-2022-157060","title":"Assessing the Burden of Adverse Events in a Head-to-Head Trial of Acalabrutinib Versus Ibrutinib in Previously Treated Chronic Lymphocytic Leukemia (CLL)","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Ibrutinib; Adverse effect; Internal medicine; Chronic lymphocytic leukemia; Incidence (geometry); Post-hoc analysis; Oncology; Leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01271755,0.0008540229,0.001716729,0.0005654158,0.0003721515,0.0008017726,0.0005378641,0.00062868,0.002411214],"category_scores_gemma":[0.008882212,0.0003174483,0.002655689,0.0006317448,0.0005369477,0.0007345343,0.000705038,0.001557354,0.0002611445],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007512663,"about_ca_system_score_gemma":0.001027856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005209305,"about_ca_topic_score_gemma":0.001689244,"domain_scores_codex":[0.9944476,0.004122761,0.0003013968,0.0003715413,0.0005001328,0.0002565857],"domain_scores_gemma":[0.9899111,0.005344688,0.002907503,0.0005499702,0.000459333,0.0008274941],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8370007,0.004629308,0.07233249,0.0009556417,0.01680654,0.0001908382,0.0002813721,0.00494704,0.006282409,0.0002332494,0.001472013,0.05486846],"study_design_scores_gemma":[0.1801226,0.4334126,0.3456729,0.0001337437,0.01576918,0.0005076762,0.0002201903,0.01444445,0.004937897,0.00122635,0.003445019,0.0001074507],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994971,0.0015663,0.0009675738,0.0001346817,0.00006981106,0.0008730884,0.0004747222,0.00003134866,0.0009113476],"genre_scores_gemma":[0.9965416,0.0003731268,0.0006392641,0.0001844662,0.00009545571,0.00113096,0.0005980149,0.000009799986,0.0004272877],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01271755,"threshold_uncertainty_score":0.06725758,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04978422610707629,"score_gpt":0.3696547688485834,"score_spread":0.3198705427415072,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}